Patent · US Active

Methods of administering interferon gamma to absorb fluid from the subretinal space

US8697046B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 14, 2009
Grant dateApr 15, 2014
Priority date
Expiry dateDec 15, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Particular aspects of the invention provide methods for decreasing the amount of fluid present in the subretinal space of the eye by administering interferon gamma to the basolateral side of the retinal pigment epithelium. Adverse ocular conditions associated with the accumulation of fluid in the subretinal space can be treated by administering an amount of interferon gamma to the basolateral side of the retinal pigment epithelium effective to remove excess fluid from the subretinal space.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.